Fosamax MDL To Wind Down More Swiftly Than Merck Wanted

Law360, New York (August 30, 2013, 5:07 PM EDT) -- A New York federal judge decided Thursday to transfer cases out of the Fosamax jaw injury multidistrict litigation against Merck & Co. Inc. at an even faster pace than proposed by the plaintiffs, who have pushed strongly for a speedy transition.

Barring a global settlement in the next two months, U.S. District Judge John Keenan will transfer 200 cases per month out of the multidistrict litigation and into their home courts beginning Nov. 1, he said in an order. Nearly 1,000 cases are pending in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.